Ignite Creation Date:
2024-05-06 @ 11:18 AM
Last Modification Date:
2024-10-26 @ 12:43 PM
Study NCT ID:
NCT03488771
Status:
UNKNOWN
Last Update Posted:
2018-04-05
First Post:
2018-03-22
Brief Title:
Evaluation of Cell-mediated Immune Response by QuantiFERON Monitor Assay in Kidney Transplant Recipients
Sponsor:
Clinical Hospital Merkur
Organization:
Clinical Hospital Merkur
Study Overview
Official Title:
Evaluation of Cell-mediated Immune Response by QuantiFERON Monitor Assay in Kidney Transplant Recipients
Status:
UNKNOWN
Status Verified Date:
2018-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
All kidney transplant recipients require immunosuppression the net level of which is difficult to assess Current practice in assessing immune reactivity is to monitor levels of some immunosuppressive drugs QuantiFERON Monitor QFM is an in vitro diagnostic test that detects interferon-γ IFN-γ release in peripheral blood Its clinical utility in assessment of the net state of immunosuppression in kidney transplant recipients has not been well studied The aim of our study is to evaluate the discriminating value of QFM testing results for infection and rejection in a single-centre cohort of kidney transplant recipients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None